2015
Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults
Abstract: Analysis 1.2. Comparison 1 SSRI or SNRI versus placebo, Outcome 2 Withdrawals-any reason.. .. .. .. Analysis 1.3. Comparison 1 SSRI or SNRI versus placebo, Outcome 3 Withdrawals due to adverse events.. .. . Analysis 1.4. Comparison 1 SSRI or SNRI versus placebo, Outcome 4 Number of patients with minor adverse events. Analysis 2.1. Comparison 2 SSRI or SNRI versus another active drug (amitriptyline), Outcome 1 Migraine frequency
Search citation statements
Paper Sections
Select...
53
14
9
3
Citation Types
3
53
0
1
Year Published
Range
2014
2026
Publication Types
Select...
60
8
2
2
Relationship
1
71
Authors
Journals
Cited by 72 publications
(57 citation statements)
References 70 publications
3
53
0
1
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…Depression (22.8%) and anxiety (13.9%) were the two most common comorbities in our dMIG population in line with the literature (10,43). The high rates of these disorders in our dMIG population may explain the preference for antidepressant use as well as the suggested role of neurotransmitters in development of headache (44).…”
Section: Discussion
supporting
confidence: 86%